Jupiter Asset Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
S
Jupiter Asset Management's NVAX Position: Q2 2026 in Review
Jupiter Asset Management opened a new position in Novavax (NVAX) in Q2 2026: 1,070,232 shares worth $10.1M. The stake represents 0.05% of the portfolio and ranks #298 among its holdings. This is a return to the name: Jupiter Asset Management previously reported a position in NVAX as recently as Q4 2025.
Jupiter Asset Management first reported a position in NVAX in Q4 2022 and has held it in 10 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Jupiter Asset Management held 1,070,232 shares of Novavax worth $10.1M as of Q2 2026.
- Novavax was a new Jupiter Asset Management position in Q2 2026.
- Novavax made up 0.05% of Jupiter Asset Management's portfolio in Q2 2026, its #298 holding.
- Jupiter Asset Management first reported a position in Novavax in Q4 2022 and has held it in 10 quarters since.
- 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.